(Q36686074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Genetic basis of hypertrophic cardiomyopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Christine L Chiu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Christopher Semsarian

series ordinal

3

object named as

Christopher Semsarian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

927-934

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

Asymmetrical hypertrophy of the heart in young adults

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Biology of the troponin complex in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Sudden death due to troponin T mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Identification of a gene responsible for familial Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Isolated noncompaction of left ventricular myocardium. A study of eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

The Genetic Basis for Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.4.6.927

21 January 2018

Identifiers

DOI

10.1586/14779072.4.6.927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17173506%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference